Agios Pharmaceuticals | AGIO - Pre Tax Profit



Agios Pharmaceuticals reported $-112020000 in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
AbbVie USD 1.66B 3.15B Mar/2025
Agios Pharmaceuticals USD -112020000 22.73M Jun/2025
Alnylam Pharmaceuticals USD -35358000 6.24M Jun/2025
Amgen USD 1.57B 405M Jun/2025
Arrowhead Research USD -179089000 548.7M Jun/2025
Astellas Pharma JPY 90.42B 29.86B Jun/2025
AstraZeneca USD 3.13B 275M Jun/2025
Bayer EUR -426000000 2.26B Jun/2025
Biogen USD 744M 432.8M Jun/2025
BioMarin Pharmaceutical USD 297.87M 59.78M Jun/2025
Bristol-Myers Squibb USD 1.77B 1.2B Jun/2025
Daiichi Sankyo JPY 105.44B 24.81B Jun/2025
Eli Lilly USD 6.78B 3.32B Jun/2025
Exelixis USD 230.42M 24.72M Jun/2025
Gilead Sciences USD 2.43B 780M Jun/2025
GlaxoSmithKline GBP 1.89B 221M Jun/2025
Incyte USD 558.01M 323.82M Jun/2025
Ionis Pharmaceuticals USD 124M 271M Jun/2025
Merck USD 6.77B 864M Jun/2025
Moderna USD -818000000 146M Jun/2025
Novartis USD 4.53B 124M Jun/2025
Novartis USD 4.53B 133M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
Regeneron Pharmaceuticals USD 1.52B 613.7M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024
Sarepta Therapeutics USD 153.64M 537.16M Jun/2025
Vertex Pharmaceuticals USD 1.28B 552.6M Jun/2025